Vericel Corp Financials

VCEL Stock  USD 34.24  0.62  1.84%   
At this time, Vericel Corp's Invested Capital Average is quite stable as compared to the past year. . Tangible Asset Value is expected to rise to about 286.5 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (12.6 M). Key indicators impacting Vericel Corp's financial analysis include:
Quarterly Earnings Growth
EPS Estimate Next Quarter
Diluted Eps
EPS Estimate Current Year
EPS Estimate Next Year
The financial analysis of Vericel Corp is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Vericel Corp includes many different criteria found on its balance sheet. For example, investors should never minimize Vericel Corp's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Vericel Corp's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Vericel Corp.

Cash and Equivalents

43.46 Million

With this module, you can analyze Vericel financials for your investing period. You should be able to track the changes in Vericel Corp individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Vericel Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vericel Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Vericel Corp's assets may result in an increase in income on the income statement.
Evaluating Vericel Corp's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Vericel Corp's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Vericel Corp's relative financial performance

Chance Of Distress

Less than 1

Very Small
Vericel Corp Ord has less than 1 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Vericel Corp stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Vericel Corp's odds of distress score SHOULD NOT be confused with the real chance of Vericel Corp Ord filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Vericel is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Vericel Corp's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Vericel Corp's official financial statements usually reflect Vericel Corp's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Vericel Corp Ord. For example, before you start analyzing numbers published by Vericel accountants, it's critical to develop an understanding of what Vericel Corp's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Vericel Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vericel Corp's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Vericel Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vericel Corp Ord. Please utilize our Beneish M Score to check the likelihood of Vericel Corp's management manipulating its earnings.

Vericel Corp Company Summary

Vericel Corp competes with Chevron Corp, JPMorgan Chase, International Business, Coca Cola, and Alcoa Corp. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people.
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0000887359
RegionNorth America
LocationMassachusetts; U.S.A
Business Address64 Sidney Street,
IndustryHealth Care
BenchmarkNYSE Composite
Phone617 588 5555
CurrencyUSD - US Dollar
You should never invest in Vericel Corp without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Vericel Stock, because this is throwing your money away. Analyzing the key information contained in Vericel Corp's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Vericel Corp Key Financial Ratios

Generally speaking, Vericel Corp's financial ratios allow both analysts and investors to convert raw data from Vericel Corp's financial statements into concise, actionable information that can be used to evaluate the performance of Vericel Corp over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Vericel Corp Ord reports annually and quarterly.

Vericel Corp Key Balance Sheet Accounts

201820192020202120222023 (projected)
Accounts Payable7.1M6.3M6.8M9.0M16.9M18.3M
Total Assets118.7M153.2M205.6M243.7M273.0M294.6M
Current Assets112.8M111.7M123.6M158.5M186.9M201.6M
Assets Non Current5.9M41.6M82.0M85.2M86.1M92.9M
Cash and Equivalents18.3M27.0M33.8M68.5M51.1M43.5M
Total Liabilities16.5M42.1M71.3M73.2M80.7M87.1M
Current Liabilities14.8M19.8M22.5M26.1M37.5M40.4M

Vericel Corp Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Vericel Corp's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201820192020202120222023 (projected)
Direct Expenses32.2M37.6M40.0M50.2M54.6M58.9M
Consolidated Income(8.1M)(9.7M)2.9M(7.5M)(16.7M)(18.0M)
Cost of Revenue32.2M37.6M40.0M50.2M54.6M45.4M
Gross Profit58.7M80.3M84.2M106.0M109.8M118.5M
Interest Expense1.1M1.7M8K4K366K380.8K
Net Income(8.1M)(9.7M)2.9M(7.5M)(16.7M)(18.0M)
Operating Expenses62.6M91.5M81.9M113.9M126.8M103.7M
Operating Income(3.9M)(11.3M)2.4M(7.9M)(17.1M)(18.4M)

Vericel Corp Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Vericel Corp Ord. It measures of how well Vericel is doing because it can show the actual money that comes into and out of the company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Vericel Corp brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Vericel had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Vericel Corp has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201820192020202120222023 (projected)
Capital Expenditure(2.7M)(2.6M)(2.6M)(7.9M)(7.6M)(7.8M)
Depreciation Amortization and Accretion1.4M4.5M2.4M3.0M4.0M3.3M
Net Cash Flow or Change in Cash and Cash Equivalents(8.6M)8.7M6.9M34.7M(17.5M)(17.9M)
Issuance Purchase of Equity Shares77.1M5.3M6.6M11.2M3.7M3.7M
Issuance Repayment of Debt Securities10.3M6.8M(17.5M)(1.1M)(968.4K)(993.9K)
Net Cash Flow from Financing58.9M5.3M6.4M9.2M1.0M1.1M
Net Cash Flow from Investing(67.0M)10.6M(17.2M)(3.5M)(36.2M)(37.2M)
Net Cash Flow from Operations(412K)(7.2M)17.6M29.0M17.7M19.1M
Share Based Compensation7.2M13.2M13.8M34.3M37.2M40.1M

Vericel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vericel Corp's current stock value. Our valuation model uses many indicators to compare Vericel Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vericel Corp competition to find correlations between indicators driving Vericel Corp's intrinsic value. More Info.
Vericel Corp Ord is rated first in number of shares shorted category among related companies. It is rated first in operating margin category among related companies . At this time, Vericel Corp's Operating Margin is quite stable as compared to the past year.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Vericel Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vericel Corp's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vericel Corp's earnings, one of the primary drivers of an investment's value.

Vericel Corp Ord Systematic Risk

Vericel Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vericel Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Vericel Corp Ord correlated with the market. If Beta is less than 0 Vericel Corp generally moves in the opposite direction as compared to the market. If Vericel Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vericel Corp Ord is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vericel Corp is generally in the same direction as the market. If Beta > 1 Vericel Corp moves generally in the same direction as, but more than the movement of the benchmark.

About Vericel Corp Financials

What exactly are Vericel Corp Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Vericel Corp's income statement, its balance sheet, and the statement of cash flows. Potential Vericel Corp investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Vericel Corp investors may use each financial statement separately, they are all related. The changes in Vericel Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vericel Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Vericel Corp Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Vericel Corp is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Vericel has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Vericel Corp's financials are consistent with your investment objective using the following steps:
  • Review Vericel Corp's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Vericel Corp's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Vericel Corp's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Vericel Corp's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Vericel Corp Thematic Clasifications

Vericel Corp Ord is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Pharmaceutical ProductsView
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas

Vericel Corp December 8, 2023 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Vericel Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vericel Corp Ord. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vericel Corp Ord based on widely used predictive technical indicators. In general, we focus on analyzing Vericel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vericel Corp's daily price indicators and compare them against related drivers.
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities.
Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Vericel Stock analysis

When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.